Salivary gland cancer is a rare heterogeneous group of neoplasms with complex histopathologic patterns, including carcinoma with squamous differentiation, for which surgery is the standard treatment. However, further research is essential for developing new therapies. Head and neck squamous cell carcinoma is positive for p63 and negative for the bicellular tight junction protein cingulin (CGN). p63 plays a key role in cancer progression such as cell proliferation, migration, apoptosis, and squamous differentiation. To understand the roles of p63 in salivary duct adenocarcinoma, we investigated the malignancy by using overexpression of deltaNp63 in p63-negative salivary duct adenocarcinoma cells PGC2E derived from parotid gland duct adenocarcinoma. By transfection with deltaNp63, the PGC2E cells exhibited increased nuclear p63 expression and reduced CGN levels at the membrane. Overexpression of deltaNp63 disrupted epithelial polarity and epithelial permeability barriers, promoted cell proliferation and migration, and enhanced cellular metabolism. Treatment with inhibitors of histone deacetylase and nuclear factor kappa B, and antibodies to tumor necrosis factor-α and tricellular tight junction protein lipolysis-stimulated lipoprotein receptor induced apoptosis in PGC2E cells. However, overexpression of deltaNp63 prevented the induced apoptosis. These findings suggest that p63 contributes to cancer malignancy and the complex phenotype, and it may be possible to develop a novel treatment via p63:
KosterMIKimSMillsAADeMayoFJRoopDR.p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 2004;18(2):126–31.
3.
XuYYangXXiongQHanJZhuQ.The dual role of p63 in cancer. Front Oncol. 2023;13:1116061.
4.
SteurerSRiemannCBüscheckFLuebkeAMKluthMHube-MaggCHinschAHöflmayerDWeidemannSFrauneCMöllerKMenzAFischMRinkMBernreutherCLebokPClauditzTSSauterGUhligRWilczakWDumDSimonRMinnerSBurandtEKrechRKrechTMarxAH.p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. Biomark Res. 2021;9(1):7.
5.
RoccoJWLeongCOKuperwasserNDeYoungMPEllisenLW.p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell. 2006;9(1):45–56.
6.
WoodstockDLSammonsMAFischerM.p63 and p53: collaborative partners or dueling rivals?Front Cell Dev Biol. 2021;9:701986.
7.
HaoYBakerDTen DijkeP.TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767.
8.
PokornáZTylichováZVojtesekBCoatesPJ.Complex and variable regulation of ΔNp63 and TAp63 by TGFβ has implications for the dynamics of squamous cell epithelial to mesenchymal transition. Sci Rep. 2024;14(1):7304.
9.
SivakumarNNarwalAPandiarDDeviAAnandRBansalDKambojM.Diagnostic utility of p63/p40 in the histologic differentiation of salivary gland tumors: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;133(2):189–98.
10.
StranskyNEgloffAMTwardADKosticADCibulskisKSivachenkoAKryukovGVLawrenceMSSougnezCMcKennaASheflerERamosAHStojanovPCarterSLVoetDCortésMLAuclairDBergerMFSaksenaGGuiducciCOnofrioRCParkinMRomkesMWeissfeldJLSeethalaRRWangLRangel-EscareñoCFernandez-LopezJCHidalgo-MirandaAMelendez-ZajglaJWincklerWArdlieKGabrielSBMeyersonMLanderESGetzGGolubTRGarrawayLAGrandisJR.The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157–60.
11.
MasudaSOdaYSasakiHIkenouchiJHigashiTAkashiMNishiEFuruseM.LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci. 2011;124(Pt 4):548–5.
12.
FuruseMOdaYHigashiTIwamotoNMasudaS.Lipolysis-stimulated lipoprotein receptor: a novel membrane protein of tricellular tight junctions. Ann N Y Acad Sci. 2012;1257:54–8.
13.
KohnoTKonnoTKojimaT.Role of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor (LSR) in cancer cells. Int J Mol Sci. 2019;20(14):3555.
14.
ShimadaHKohnoTKonnoTOkadaTSaitoKShindoYKikuchiSTsujiwakiMOgawaMMatsuuraMSaitoTKojimaT.The roles of tricellular tight junction protein angulin-1/Lipolysis-stimulated lipoprotein receptor (LSR) in endometriosis and endometrioid-endometrial carcinoma. Cancers (Basel). 2021;13(24):6341.
15.
CordenonsiMD’AtriFHammarEParryDAKendrick-JonesJShoreDCitiS.Cingulin contains globular and coiled- coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol. 1999;147:1569–82.
16.
YanoTMatsuiTTamuraAUjiMTsukitaS.The association of microtubules with tight junctions is promoted by cingulin phosphorylation by AMPK. J Cell Biol. 2013;203:605–14.
17.
KonnoTKohnoTKikuchiSShimadaHSatohisaSTakanoKSaitoTKojimaT.Localization of tricellular tight Junction molecule LSR at midbody and centrosome during cytokinesis in human epithelial cells. J Histochem Cytochem. 2020;68:59–72.
18.
NakanoMOhwadaKShindoYKonnoTKohnoTKikuchiSTsujiwakiMIshiiDNishidaSKakukiTObataKMiyataRKuroseMKondohATakanoKKojimaT.Inhibition of HDAC and signal transduction pathways induces tight junctions and promotes differentiation in p63-positive salivary duct adenocarcinoma. Cancers. 2022;14(11):2584.
19.
MaoXLiHMinSSuJWeiPZhangYHeQWuLYuGCongX.Loss of tricellular tight junction tricellulin leads to hyposalivation in Sjogren’s syndrome. Int J Oral Sci. 2025;17(1):22.
20.
ZhangXYunJSHanDYookJIKimHSChoES.TGF-β pathway in salivary gland fibrosis. Int J Mol Sci. 2020;21(23):9138.
21.
LoomansHAAndlCD.Intertwining of activin A and TGFβ signaling: dual roles in cancer progression and cancer cell invasion. Cancers. 2014;7(1):70–91.
22.
MurakamiMKamimuraDHiranoT.Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity. 2019;50(4):812–31.
23.
WeiLXiongHLiWLiBChengY.Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF-κB pathways. J Oral Pathol Med. 2018;47(9):847–55.
24.
VälimaaHSavolainenSSoukkaTSilvoniemiPMäkeläSKujariHGustafssonJALaineM.Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol. 2004;180(1):55–62.
25.
WarnerMWuWFMontanholiLNalvarteIAntonsonPGustafssonJA.Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERβ gene. Proc Natl Acad Sci U S A. 2020;117(9):4902–9.
26.
ZhaoBTumanengKGuanKL.The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13(8):877–3.
27.
Low-CalleAMGhoneimaHOrtegaNCuibusAMKatzCPrivesCPrywesR.A non-canonical Hippo pathway represses the expression of ΔNp63. Mol Cell Biol. 2024;44(1):27–42.
28.
SonnemannJGängeJKumarKSMüllerCBaderPBeckJF.Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. Invest New Drugs. 2005;23(2):99–109.
29.
ShinMWSeoSYKimSLKimSW.HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells. Cell Mol Biol (Noisy-le-grand). 2023;69(5):12–8.
30.
ShahRR.Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology. Drug Saf. 2019;42(2):235–45.
31.
LivaSChenMMortazaviAWalkerAWangJDittmarKHofmeisterCCossCCPhelpsMA.Population pharmacokinetic analysis from first-in-human data for HDAC inhibitor, REC-2282 (AR-42), in patients with solid tumors and hematologic malignancies: A case study for evaluating flat vs. body size normalized dosing. Eur J Drug Metab Pharmacokinet. 2021;46(6):807–16.
32.
ChikamatsuKIshiiHMurataTSakakuraKShinoMToyodaMTakahashiKMasuyamaK.Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck. Cancer Sci. 2013;104(11):1468–75.
33.
ArtsJKingPMariënAFlorenWBeliënAJanssenLPilatteIRouxBDecraneLGilissenRHicksonIVreysVCoxEBolKTalloenWGorisIAndriesLDu JardinMJanicotMPageMvan EmelenKAngibaudP.JNJ- 26481585, a novel “second-generation” oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity. Clin Cancer Res. 2009;15(22):6841–51.
34.
BaoLDiaoHDongNSuXWangBMoQYuHWangXChenC.Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation. Cell Biol Toxicol. 2016;32(6):469–82.
35.
HeBDaiLZhangXChenDWuJFengXZhangYXieHZhouLWuJZhengS.The HDAC inhibitor quisinostat (JNJ-26481585) supresses hepatocellular carcinoma alone and synergistically in combination with sorafenib by G0/G1 phase arrest and apoptosis induction. Int J Biol Sci. 2018;14(13):1845–58.
36.
SaitoKKonnoTKohnoTShimadaHMatsuuraMOkadaTKuraAIshiiDKondohMSaitoTKojimaT.LSR antibody promotes apoptosis and disrupts epithelial barriers via signal pathways in endometrial cancer. Tissue Barriers. 2023;11(3):2106113.
37.
NishidaSKonnoTKohnoTOhyanagiMNakanoMOhwadaKObataKKakukiTKakiuchiAKuroseMTakanoKKojimaT. Treatment with TNFα and lipolysis-stimulated lipoprotein receptor (LSR) antibody in the presence of HDAC inhibitors promotes apoptosis in human salivary duct adenocarcinoma. Tissue Barriers. 2024:2437215.
38.
MoritaSKojimaTKitamuraT.Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7(12):1063–6.
39.
SuYLongYXieK.Cingulin family: structure, function and clinical significance. Life Sci. 2024;341:122504.
40.
HuangYTHsuYTWuPYYehYMLinPCHsuKFShenMR.Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition. J Exp Clin Cancer Res. 2024;43(1):65.
41.
KuraASaitoKKonnoTKohnoTShimadaHOkadaTNishidaSIshiiDMatsuuraMSaitoTKojimaT.The roles of tight junction protein cingulin in human endometrioid endometrial cancer. Tissue Barriers. 2025;13(2):2361976.
42.
ZhouXWangSWangZFengXLiuPLvXBLiFYuFXSunYYuanHZhuHXiongYLeiQYGuanKL. Estrogen regulates Hippo signaling via GPER in breast cancer. J Clin Invest. 201;125(5):2123–35.
43.
ViticchièGAgostiniMLenaAMManciniMZhouHZollaLDinsdaleDSaintignyGMelinoGCandiE. p63 supports aerobic respiration through hexokinase II.Proc Natl Acad Sci U S A. 2015;112(37):11577–82.
44.
Martínez-LimónAJoaquinMCaballeroMPosasFde NadalE.The p38 pathway: from biology to cancer therapy. Int J Mol Sci. 2020;21(6):1913.
45.
OyanagiMKakiuchiAYamamotoKKuroseMTakanoK.Paraneoplastic neurological syndromes associated with parotid cancer expressing the Zic4 antibody: a case report. Cureus. 2025;17(8):e90210.
